Aether Industries Limited (BOM:543534)
India
· Delayed Price · Currency is INR | Market Cap | 155.25B |
| Revenue (ttm) | 10.95B |
| Net Income (ttm) | 2.16B |
| Shares Out | n/a |
| EPS (ttm) | 16.25 |
| PE Ratio | 71.96 |
| Forward PE | 54.82 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 19,491 |
| Average Volume | 24,299 |
| Open | 1,112.70 |
| Previous Close | 1,114.10 |
| Day's Range | 1,103.90 - 1,167.05 |
| 52-Week Range | 723.15 - 1,250.00 |
| Beta | n/a |
| RSI | 55.97 |
| Earnings Date | Apr 30, 2026 |
About Aether Industries
Aether Industries Limited produces and sells advanced intermediates and specialty chemicals in India and internationally. It also large-scale manufacturing, contract research and manufacturing services, as well as contract/exclusive manufacturing services. The company serves its products to the chemical industry, including multinational, regional, and domestic companies in the pharmaceuticals, agrochemicals, materials science, textiles, coatings, high-performance photography, additives, and oil and gas industries. It also exports its products. ... [Read more]
Financial Performance
In fiscal year 2025, Aether Industries's revenue was 8.41 billion, an increase of 40.20% compared to the previous year's 6.00 billion. Earnings were 1.58 billion, an increase of 92.05%.
Financial StatementsNews
Aether Industries Transcript: Q3 25/26
Revenue and profit grew strongly year-on-year, driven by robust performance across all business segments and new client additions. Major site expansions and R&D investments are underway, with a focus on non-pharma sectors and strategic global partnerships.
Aether Industries Transcript: Q2 25/26
Q2 FY 2026 saw 38% revenue growth and 70% EBITDA growth year-over-year, with CEM and CRAMS now over 50% of sales. CapEx and R&D expansions are on track, supporting a 25% annual growth outlook and sustainable 29%-31% EBITDA margins.
Aether Industries Transcript: Q1 25/26
Q1 FY26 revenue grew 35% year-on-year, with strong EBITDA and PAT margin expansion. Major new contracts, ongoing CapEx, and robust demand in large-scale and contract manufacturing support a positive outlook, while India benefits from global supply chain shifts.
Aether Industries Transcript: Q4 24/25
Q4 and FY25 saw robust volume and revenue growth, with margins expanding on the back of strong CRAMS and CEM performance. Expansion projects and R&D investments are progressing, while working capital and return ratios improved. Outlook remains positive with stable margins and a diversified revenue mix.
Aether Industries Transcript: Q3 24/25
Q3 FY25 saw double-digit revenue and profit growth, margin expansion, and strong volume gains. Major capacity expansions, new product launches, and strategic partnerships are set to drive future growth, with a focus on sustainability and improved working capital cycles.
Aether Industries Transcript: Q2 24/25
Q2 FY25 saw 9% QoQ revenue growth and margin improvement despite Chinese pricing pressure. Capacity utilization and new client additions were strong, with major CapEx and sustainability initiatives progressing. Margins and pricing are expected to improve from Q4 FY25.
Aether Industries Transcript: Q1 24/25
Q1 FY25 saw strong volume growth and margin recovery, with revenue up 49% sequentially and EBITDA margin rising to 23%. Delays from a site accident shifted some project timelines, but major expansions and new strategic agreements, especially with Baker Hughes, are set to drive growth in coming quarters.